Keywords: SSc; Scleroderma; Systemic sclerosis; Monoclonal autoantibodies; PDGFR; AECA; AT1R/ETAR; M3R;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: AA-PEG; aminoethylanisamide-polyethylene glycol; AD; Alzheimer's disease; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; CML; Chronic Myeloid Leukemia; CPPs; cell penetrating peptides; c(RGDyK; cyclo(Arg-Gly-Asp-D-Tyr-Lys) peptide; DSP
Keywords: Ang-II; angiotensin-II; CDKs; cyclin-dependent kinases; ChGn; chondroitin N-acetylgalactosaminyltransferase; ChPF; chondroitin polymerizing factor; ChSy; chondroitin synthase; CS; chondroitin sulfate; CVDs; cardiovascular diseases; C4S; chondroitin-4-sulf
Keywords: ACSVL3; acyl-coA synthetase VL3; ALDH1; aldehyde dehydrogenase; ALDOA; aldolase A; ALDOC; aldolase C; AMPK; 5â² AMP-activated protein kinase; ASNS; asparagine synthetase; BTICs; brain tumor initiating cells; 3-BrOP; 3-bromo-2-oxopropionate-1-propyl ester
Keywords: BM; bone marrow; BMCs; bone marrow-derived cells; CD; cardiospheres-derived; CPCs; cardiac progenitor cells; CS; cardiospheres; CV; cardiovascular; CXCR4; C-X-C chemokine receptor type 4; Dil-Ac-LDL; 1,1â²-dioctadecyl-3,3,3â²,3â²-tetramethylindocarbocy
Keywords: AS; activation segment; CS or C-spine; catalytic spine; CL; catalytic loop; CTT; carboxyterminal tail; D1; immunoglobulin-like domain-1; EGFR; epidermal growth factor receptor; GIST; gastrointestinal stromal tumors; GK; gatekeeper; GRL; Gly-rich loop; KD;
Keywords: ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: Brain tumor; Glioblastoma; CMV; Oncomodulatory agent; CMV; Cytomegalovirus; GBM; Glioblastoma Multiforme; EGFR; Epidermal growth factor receptor; PDGFR; Platelet-derived growth factor receptor; ER; Endoplasmic reticulum; GSC; Glioma stem cells; NPC; Neura
Keywords: Hypereosinophilic syndrome; Monoclonal antibody; IL-5; AEC; Absolute eosinophil count; CEL-NOS; Chronic eosinophilic leukemia-not otherwise specified; EGID; Eosinophilic gastrointestinal disorder; EGPA; Eosinophilic granulomatosis with polyangiitis; EoE;
Keywords: 4-HDDE; 4-Hydroxy-2E,6Z-dodecadienal; 4-HHE; 4-Hydroxyl-2E-hexenal, 4-HNE, 4-Hydroxy-2E-nonenal; AGE; Advanced glycation end products; ALE; Advanced lipoxidation end products; AR; aldose reductase; COX; Cyclooxygenase; EET; Epoxyeicosatrienoic acid; ER; E
Keywords: Notochordal tumor; Chordoma; Benign notochordal cell tumor (BNCT); Molecular pathology; Targeted therapy; Brachyury (T); EGFR; PDGFR;
Keywords: Aptamer; Apoptosis; Targeted therapy; Intrinsic apoptosis pathway; Extrinsic apoptosis pathway; Intramer; Akt; PKB (protein kinase B); Bcl; B-cell lymphoma family protein; BH; Bcl-2 homology domain; Bmi-1; B lymphoma Mo-MLV insertion region 1; CD; cluster
Keywords: 7AAD; 7-aminoactinomycin D; αSMA; alpha smooth muscle actin; AKT; protein kinase B; ALK; activin receptor-like kinase; Ang; angiopoietin; Ang II; angiotensin II; BCRP1; breakpoint cluster region pseudogene; bFGF; basic fibroblast growth factor; C1P; cera
Keywords: Ac; acetyl group; AUC; area under the curve; BBB; Blood-brain barrier; BCRP; breast cancer resistance protein; CDK; cyclin-dependent kinase; CLIA; Clinical Laboratory Improvement Amendments; CNS; Central nervous system; CNS-TAP; CNS Targeted Agent Predict
Keywords: Systemic lupus erythematosus; Lupus nephritis; Genetics; APOL1; PDGFR; HAS2;
Keywords: CAF; Colon Cancer; IBD; Mesenchyme; α-SMA; α-smooth muscle actin; AOM; azoxymethane; BMP; bone morphogenetic protein; CAC; colitis-associated cancer; CAF; cancer-associated fibroblast; CCL; C-C motif chemokine ligand; COX-2; cyclooxygenase 2; CRC; co
Keywords: TME; tumor microenvironment; NHSC; non hematopoietic stromal cells; MSC; mesenchymal stem cells; MF; myofibroblasts; CAF; cancer associated fibroblasts PGE2 prostaglandin E2; VEC; vascular endothelial cells; LEC; lymphatic endothelial cells; PDGFR; platel
Keywords: Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: Ab; Abelson; CD; Crohn's disease; CML; Chronic myeloid leukemia; DAI; Disease activity index; DC; Dentritic cell; IBD; Inflammatory bowel disease; IL; Interleukin; LGL; Large granular lymphocytosis; MDA; Malondialdehyde; MPO; Myeloperoxidase; NFкβ; Nucl
Keywords: PTP; protein tyrosine phosphatase; PTK; protein tyrosine kinase; LMW-PTP; low molecular weight protein tyrosine phosphatase; LMW-AP; low molecular weight acid phosphatase; ACP1; gene coding for human LMW-PTP; PTP1B; tyrosine-protein phosphatase non-recept
Keywords: Beta cells; Diabetes; Eicosanoids; Fatty aldehyde dehydrogenase; Glutathione peroxidase; Glutathione-S-transferase4-hydroxyalkenals; 4-Hydroxynonenal; Lipid peroxidation; Phospholipase A; 12-HETE (PubChem CID: 5283155); 15-HETE (PubChem CID: 280724); 4-HN
Keywords: Afatinib (PubMed CID: 10184653); Crizotinib (PubMed CID: 11626560); Erlotinib (PubMed CID: 176870); Gefitinib (PubMed CID: 123631); Imatinib (PubMed CID: 5291); Nilotinib (PubMed CID: 644241); Sorafinib (PubMed CID: 216239); Sunitinib (PubMed CID: 5329102
Keywords: Tyrosine kinase inhibitors; Drug transporter; Drug interaction; Therapeutic drug monitoring; Skin disorders; ADR; Adverse drug reaction; AUC; Area under the curve; BBB; Blood-brain barrier; BCRP/ABCG2; Breast cancer resistance protein; CNS; Central nerv
Keywords: AD; Alzheimer's disease; CGT; UDP-galactose ceramide galactosyltransferase; CNS; central nervous system; CST; cerebroside sulfotransferase; GalCer; galactosylceramide; GlcCer; glucosylceramide; GCS; glucosylceramide synthase; GPI; glycosylphosphatidylinos
Keywords: VEGF; vascular endothelial growth factor; TGF-β; transforming growth factor-β; ECM; extracellular matrix; EC; endothelial cell; SPARC; secreted protein acidic and rich in cysteine; PG; proteoglycan; GAG; glycosaminoglycan; SLRP; small leucine-rich prote
Keywords: tyrosine kinase inhibitors; diabetes mellitus; c-Abl; PDGFR; VEGFR; EGFR
Keywords: AA; arachidonic acid; Aβ; fibrillar β-amyloid; ACC; acetyl-CoA carboxylase; Akt; protein kinase B; APP; amyloid precursor protein; ASAH2; neutral ceramidase; BA; benzyl alcohol; BBB; blood-brain-barrier; BMI; body mass index; BPM; bis(monoacylglycero)
Keywords: %ID/g; percent injected dose per gram; 125I-FIAU; 125I-labeled fialuridine; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-FMT; 18F-labeled D-fluoromethyl tyrosine; ADC; apparent diffusion coefficient; BLI; bioluminesce
Keywords: AKAP; A-Kinase Anchoring Protein; ALL; acute lymphoblastic leukemia; A.S.; activation segment; CDK; cyclin-dependent kinase; CML; chronic myelogenous leukemia; C-spine; catalytic spine; EGFR; epidermal growth factor receptor; FGFR; fibroblast growth facto
Keywords: 18F-FAZA; 18F-labeled fluoroazomycin arabinoside; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-HX4; 18F-labeled flortanidazole; 18F-MISO; 18F-labeled fluoromisonidazole; 62Cu-ATSM; 62Cu-labeled diacetyl-bis(N-methylth
Keywords: EI; eye iris; MSC; mesenchymal stem cells; PDGF; platelet-derived growth factor; PDGFR; platelet-derived growth factor receptor; VEGF; vascular endothelial growth factor; Stem cells; Progenitor cells; Circulating fibrocytes; Fibroblasts; Angiogenesis; Iri
Keywords: CTGF; connective tissue growth factor; ECM; extracellular matrix; EMT; epithelial-mesenchymal-transition; EndMT; endothelial-mesenchymal-transition; FGF; fibroblast growth factor; IL; interleukin; MMP; matrix metalloproteinase; TGF; transforming growt
Keywords: ROS; Oxidative stress; Mitochondria; Stroma; Myofibroblast; CAF heterogeneity; Actin; PDGFR; Caveolin
Keywords: ALI; acute lung injury; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; LPS; lipopolysaccharide; MMP; matrix metalloproteinase; NRTK; nonreceptor tyrosine kinase; PDGF; platelet-derived growth factor; PDGFR; platelet-derived growth fact
Keywords: aFGF; acidic fibroblast growth factor; Ang-2; angiopoietin-2; bFGF; basic fibroblast growth factor; Conc; concentration; FGFR; fibroblast growth factor receptor; G-CSF; granulocyte colony-stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulati
Keywords: ANXA 1; annexin A1; APA; aminopeptidase A; APN; aminopeptidase N; APP; aminopeptidase P; BBB; blood-brain barrier; CT; computed tomography; CREG1; cellular repressor of E1A-stimulated genes 1; DDL4; delta like ligand 4; DLP; dynamin-1 like protein; Eph-
Keywords: AAV; adeno-associated virus; Aex; ascites-derived exosomes; BACE1; beta secretase 1; BAP-TM; biotin acceptor peptide-transmembrane domain; CAM; cell adhesion molecule; CD; cluster of differentiation; CD; cytosine deaminase; Dex; dendritic cell-derived exo
Keywords: BSA; bovine serum albumin; CI; combination index; DRI; dose-reduction index; DTNB; 5,5-dithio-bis (2-nitrobenzoic acid); DMSO; dimethyl sulfoxide; EAC; Ehrlich ascites carcinoma; FBS; fetal bovine serum; GIST; gastrointestinal stromal tumor; GSH; glutathi
Keywords: Guanidine; Sorafenib; Protein kinases; RAF-1; MEK-1; Docking; EGFR; Epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; HB; hydrogen bond; MAPK; Mitogen-activated protein kinase; MEK; Mitogen-activated protein/extracellular signa
Keywords: S/B; signal to background; PDGFR; platelet-derived growth factor receptor; BTK; Bruton's tyrosine kinase; EGFR; epidermal growth factor receptor; HER-2; human epidermal growth factor 2; AMPK; AMP activated protein kinase; BMPR; bone morphogenetic protei
Keywords: BRAF; B-Raf protein; BRD4; bromodomain-containing protein 4; CDK6; cyclin-dependent kinase 6; ERBB1; epidermal growth factor receptor; ERG; ETS-family oncogenic transcription factor; ERK; extracellular signal regulated protein kinase; FOS; FBJ murine oste
Keywords: 5-HT (5-hydroxytryptamine); serotonin; TPH1; tryptophan hydroxylase 1; 5HTR; 5-HT receptor; 5HTT; 5-HT transporter; PDGF; platelet derived growth factor; PDGFR; platelet derived growth factor receptor; SMA; smooth muscle actinECs pulmonary arterial endoth
Keywords: ANA; anti-nuclear antibody; ATA; anti-topoisomerase antibody; AMA; anti-mitochondrial antibody; AAV; ANCA associated vasculitis; AFA; anti-fibroblast antibody; AECA; anti-endothelial cell antibody; anti-CCP; anti-cyclic citrullinated peptide; anti-CENP; a
Keywords: EGFR; Epidermal growth factor receptor; FITC; Fluorescein isothiocyanate; GPCR; G protein coupled receptor; IP3; Inositol-tris-phosphate; PIP2; Phosphatidyl-inositol-bis-phosphate; PLCγ; Phospholipase Cγ; PKA/C; Protein kinase A/C; PDGFR; Platelet-deriv
Keywords: AMPK; AMP activated protein kinase; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; ERK; extracellular signal-regulated kinase; FLIP; FLICE inhibitory protein; FAK; focal adhesion kinase; GSK-3;
Keywords: SAH; early brain injury; PDGFR; apoptosis; encephaledema
Preliminary in vitro and in vivo investigation of a potent platelet derived growth factor receptor (PDGFR) family kinase inhibitor
Keywords: Kinase inhibitor; PDGFR; KIT; Cancer; Systemic mastocytosis;
MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells
Keywords: MeHg; methylmercury; Ca2+; Calcium; Rac1; ras related C3 botulinum toxin substrate 1; Cdc42; cell division control protein 42 homolog; RhoA; ras homolog gene family member A; GD; gestation day; PND; postnatal day; FAK; focal adhesion kinase; p-FAKY397; FA
Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubes
Keywords: Mitochondria; Complex activities; C2C12 cells; Cytotoxicity; Tyrosine kinase inhibitors; Glucose and nucleoside uptake; BCR; breakpoint cluster region; ABL; Abelson murine leukemia; PDGFR; platelet derived growth factor receptor; VEGFR; vascular endotheli